Inventor · San Francisco, CA, US

John Buell

14Patents

5h-index

31Co-inventors

62Inventor score

Filing activity: Sep 5, 2013 → Oct 25, 2023

Most-cited inventions

Patent	Title	Area	Cited by	Status
US9718847B2	Heterocyclic compounds and uses thereof	Emerging Cross-Sectional Technologies	31	Active
US9771369B2	Compounds and methods for kinase modulation, and indications therefor	Chemistry; Metallurgy	23	Active
US10160755B2	Compounds and methods for kinase modulation, and indications therefor	Chemistry; Metallurgy	12	Active
US10160747B2	Compounds and methods for kinase modulation, and indications therefor	Chemistry; Metallurgy	7	Active
US10227357B2	Compounds and methods for kinase modulation, and indications therefor	Chemistry; Metallurgy	6	Active
US10508085B2	Compounds and methods for IDO and TDO modulation, and indications therefor	Chemistry; Metallurgy	5	Active
US10519177B2	Heterocyclic compounds and uses thereof	Emerging Cross-Sectional Technologies	3	Active
US10703757B2	Compounds and methods for CDK8 modulation and indications therefor	Chemistry; Metallurgy	3	Active
US11739101B2	Bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses thereof	Chemistry; Metallurgy	1	Active
US11446287B2	Compounds and methods for EP300 or CBP modulation and indications therefor	Chemistry; Metallurgy	1	Active
US11807626B2	Compounds and methods for CD73 modulation and indications therefor	Chemistry; Metallurgy	1	Active
US11149011B2	Compounds and methods for IDO and TDO modulation, and indications therefor	Chemistry; Metallurgy	1	Active
US12202818B2	Compounds and methods for CD73 modulation and indications therefor	Chemistry; Metallurgy	0	Active
US12091426B2	Bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses thereof	Human Necessities	0	Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.